Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $651.25 | 35 | 96.8% |
| Education | $21.70 | 1 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $236.40 | 14 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $104.62 | 6 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $73.63 | 3 | $0 (2021) |
| Merck Sharp & Dohme LLC | $57.64 | 3 | $0 (2022) |
| Boston Scientific Corporation | $42.54 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $24.91 | 2 | $0 (2021) |
| Chiesi USA, Inc. | $23.92 | 1 | $0 (2018) |
| Insmed, Inc. | $23.60 | 1 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $22.98 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.80 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $21.70 | 1 | Merck Sharp & Dohme LLC ($21.70) |
| 2021 | $287.06 | 16 | E.R. Squibb & Sons, L.L.C. ($152.15) |
| 2020 | $104.58 | 6 | E.R. Squibb & Sons, L.L.C. ($53.04) |
| 2019 | $199.75 | 10 | Boston Scientific Corporation ($42.54) |
| 2018 | $40.06 | 2 | Chiesi USA, Inc. ($23.92) |
| 2017 | $19.80 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19.80) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/27/2021 | CMP Pharma, Inc. | Carospir (Drug) | Food and Beverage | Cash or cash equivalent | $11.80 | General |
| Category: Cardiology | ||||||
| 08/27/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/30/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.92 | General |
| Category: Cardiovascular | ||||||
| 06/25/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: Cardiovascular | ||||||
| 06/18/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.05 | General |
| Category: Cardiovascular | ||||||
| 06/16/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $31.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/21/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.96 | General |
| Category: Cardiovascular | ||||||
| 05/07/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.25 | General |
| Category: Cardiovascular | ||||||
| 04/23/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Cardiovascular | ||||||
| 04/09/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/08/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Cardiovascular | ||||||
| 03/12/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.24 | General |
| Category: Cardiovascular | ||||||
| 03/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/15/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Cardiovascular | ||||||
| 12/18/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: Cardiovascular | ||||||
| 12/17/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Cardiovascular | ||||||
| 02/26/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/07/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.36 | General |
| Category: Cardiovascular | ||||||
| 12/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/25/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $17.94 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 230 | 1,741 | $157,697 | $103,387 |
| 2022 | 2 | 40 | 97 | $20,287 | $14,711 |
| 2021 | 3 | 165 | 300 | $73,560 | $29,328 |
| 2020 | 4 | 311 | 514 | $139,230 | $55,290 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 253 | $50,489 | $37,168 | 73.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 711 | $43,680 | $28,899 | 66.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 379 | $29,942 | $20,127 | 67.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 17 | 177 | $12,390 | $6,031 | 48.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 103 | $7,210 | $4,386 | 60.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 67 | $4,690 | $3,113 | 66.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $3,600 | $1,684 | 46.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $5,270 | $1,677 | 31.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 15 | 17 | $425.00 | $300.90 | 70.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 76 | $15,172 | $11,592 | 76.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $5,115 | $3,118 | 61.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 81 | 214 | $47,294 | $18,810 | 39.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 33 | $14,124 | $5,618 | 39.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 53 | 53 | $12,142 | $4,900 | 40.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 125 | 325 | $73,413 | $29,165 | 39.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 91 | 93 | $40,836 | $16,182 | 39.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 80 | 81 | $18,954 | $7,550 | 39.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 15 | 15 | $6,027 | $2,393 | 39.7% |
About Dr. Yeyong Shin, DO
Dr. Yeyong Shin, DO is a Hospitalist healthcare provider based in Montclair, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1679831028.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yeyong Shin, DO has received a total of $672.95 in payments from pharmaceutical and medical device companies, with $21.70 received in 2022. These payments were reported across 36 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($651.25).
As a Medicare-enrolled provider, Shin has provided services to 746 Medicare beneficiaries, totaling 2,652 services with total Medicare billing of $202,715. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Family Medicine
- Location Montclair, CA
- Active Since 04/23/2012
- Last Updated 10/13/2017
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1679831028
Products in Payments
- ELIQUIS (Drug) $251.37
- XARELTO (Drug) $104.62
- LifeVest (Device) $73.63
- WATCHMAN (Device) $42.54
- CLEVIPREX (Drug) $23.92
- Arikayce (Drug) $23.60
- ANDEXXA (Biological) $22.98
- VERQUVO (Drug) $21.70
- STIOLTO (Drug) $19.80
- DIFICID (Drug) $18.00
- Adempas (Drug) $16.14
- BRILINTA (Drug) $14.01
- Carospir (Drug) $11.80
- LOKELMA (Drug) $10.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Montclair
Ali Salem, M.d, M.D
Hospitalist — Payments: $4,033
Dr. Atif Qadeer, Md, MD
Hospitalist — Payments: $1,717
Andres Gonzalez, M.d, M.D
Hospitalist — Payments: $1,562
Hammad Shaikh, M.d, M.D
Hospitalist — Payments: $1,342
Dr. Nicole Sims, D.o, D.O
Hospitalist — Payments: $190.12
Mohammed Al-Khayyat, M.d, M.D
Hospitalist — Payments: $102.31